Investor Relations
Welcome to MedVasc's Investor Relations website!
We appreciate your interest in our company and we are dedicated to providing all our current and future investors with timely and transparent information. If you have any questions, regarding our traction, investment strategy or future opportunities for investment, please feel free to reach out to CEO Cathrin Johansson.
Stay up to date on our performance and future investment opportunities by signing up to our newsletter.
Latest news
MedVasc selected to join accelerator powered by Medtronic
August 30, 2023
MedVasc has been selected to join prestigious medtech ac MedVasc has been selected as 1 of 11 international medtech startups to learn from Medtronic and MedLim partners how to accelerate commercialization. It…
Successful closing of SEK 3 million investment round
August 30, 2023
MedVasc has closed an investment round of 3 M SEK. The investors include several Life science investors such as Life Science Invest Gamma, but…
Medvasc’s patent portfolio has been granted in key licensing markets
January 20, 2023
In the fall of 2022, the patent authorities of India, Canada, and Brazil announced that they intend to grant MedVasc’s patent. MedVasc’s patent portfolio…
MedVasc selected to join accelerator powered by Medtronic
August 30, 2023
MedVasc has been selected to join prestigious medtech ac MedVasc has been selected as 1 of 11 international medtech startups to learn from Medtronic and MedLim partners how to accelerate commercialization. It…
Successful closing of SEK 3 million investment round
August 30, 2023
MedVasc has closed an investment round of 3 M SEK. The investors include several Life science investors such as Life Science Invest Gamma, but…
Medvasc’s patent portfolio has been granted in key licensing markets
January 20, 2023
In the fall of 2022, the patent authorities of India, Canada, and Brazil announced that they intend to grant MedVasc’s patent. MedVasc’s patent portfolio…
